✦ LIBER ✦

Platelet glycoprotein IIb/IIIa receptor blockade with abciximab reduces ischemic complications in patients undergoing directional coronary atherectomy

✍ Scribed by Sasan Ghaffari; Dean J. Kereiakes; A.Michael Lincoff; Thomas A. Kelly; Gerald C. Timmis; Neal S. Kleiman; James J. Ferguson; David P. Miller; Robert A. Califf; Eric J. Topol

Book ID: 113979591
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 96 KB
Volume: 82
Category: Article
ISSN: 0002-9149
DOI: 10.1016/s0002-9149(98)00238-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Platelet inhibition by abciximab reduced

Platelet inhibition by abciximab reduced in patients with the A2 allele of the glycoprotein IIb/IIIa receptor

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

Evidence for Prevention of Death and Myo

Evidence for Prevention of Death and Myocardial Infarction With Platelet Membrane Glycoprotein IIb/IIIa Receptor Blockade by Abciximab (c7E3 Fab) Among Patients With Unstable Angina Undergoing Percutaneous Coronary Revascularization

✍ A.Michael Lincoff; Robert M. Califf; Keaven M. Anderson; Harlan F. Weisman; Fran 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 233 KB

Risk of bleeding in elderly patients und

Risk of bleeding in elderly patients undergoing percutaneous coronary intervention using radial access with and without concomitant glycoprotein IIb/IIIa receptor blockade

✍ C. Boulanger-Gobeil; J.-P. Dery; É. Larose; O. Bertrand; J. Rodés-Cabau; B. Noël 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 51 KB

1139-53 The long-term clinical results o

1139-53 The long-term clinical results of a platelet glycoprotein IIb/IIIa receptor blocker (Abciximab: ReoPro®) coated stent in patients with coronary artery disease

✍ Weon Kim; Myung Ho Jeong; Young Keun Ahn; Ju Han Kim; Young Joon Hong; Jeong Gwa 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Analysis of bleeding complications assoc

Analysis of bleeding complications associated with glycoprotein IIb/IIIa receptors blockade in patients with high-risk acute coronary syndromes: Insights from the PRISM-PLUS study

✍ Thao Huynh; Nicolo Piazza; Peter M. DiBattiste; Steven M. Snapinn; Ying Wan; Cha 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 107 KB

Laboratory Monitoring of Heparin and the

Laboratory Monitoring of Heparin and the Combination of Heparin and the Platelet Glycoprotein IIb/IIIa Receptor Antibody Fragment Abciximab (c7E3) in Patients Undergoing Percutaneous Transluminal Coronary Angioplasty (PTCA)

✍ Ralf Zahn; Hannelore Haubelt; Sabine Bechtloff; Steffen Schneider; Birgit Frilli 📂 Article 📅 2003 🏛 Urban and Vogel 🌐 German ⚖ 356 KB